Literature DB >> 43494

Immunoreactive somatostatin release from rat spinal cord in vitro.

M Sheppard, S Kronheim, C Adams, B Pimstone.   

Abstract

A calcium-dependent release of immunoreactive somatostatin from rat spinal cord in vitro in response to two depolarising stimuli (60 mM KCl and 75 micrometer veratrine) has been demonstrated. Released somatostatin immunoreactivity comprised 0.53% of total tissue content, showed parallelism when serial dilutions were compared to the immunoassay dose-response curve and eluted similarly to synthetic somatostatin on Sephadex G-25 (f) chromatography. These results provide further evidence for a neurotransmitter or neuromodulator role for somatostatin in mammalian spinal cord.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 43494     DOI: 10.1016/0304-3940(79)91531-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Huntington's chorea-- measurements of somatostatin, substance P and cyclic nucleotides in the cerebrospinal fluid.

Authors:  H Cramer; J Kohler; G Oepen; G Schomburg; E Schröter
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

2.  Characterization of immunoreactive somatostatin released from rat nervous system in vitro.

Authors:  M C Sheppard; S Hendricks; A Hudson; S R Kronheim
Journal:  Biochem J       Date:  1982-02-01       Impact factor: 3.857

3.  Somatostatin-like immunoreactivity in the cerebrospinal fluid of neurological patients.

Authors:  J Kohler; E Schröter; H Cramer
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1982

4.  Effect of capsaicin pretreatment on capsaicin-evoked release of immunoreactive somatostatin and substance P from primary sensory neurons.

Authors:  R Gamse; D Lackner; G Gamse; S E Leeman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-02       Impact factor: 3.000

5.  Lack of effect of baclofen on substance P and somatostatin release from the spinal cord in vitro.

Authors:  J Sawynok; N Kato; V Havlicek; F S LaBella
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.